• Indirect testing, and therefore useful when the pathogens are hiding, but eliciting an immune response.
• Active infection may be indicated when either IgM only, IgM and IgG, or IgG (≥ 160) antibodies are present.
$160.00
The Babesia Immunofluorescence Assay (IFA) is designed to detect human IgM and IgG antibodies to Babesia antigens in human serum. Titers rise during the first two-to-four weeks of illness and then decline over the next six-to-12 months. In patients with previously high titers, an IgG titer of less than 160 may indicate a resolving infection. If the IFA is negative but clinical symptoms are present, PCR and/or FISH testing are suggested.
Babesia is carried by the same species of ticks that cause Ehrlichiosis, Bartonellosis, and Lyme disease. Therefore, patients with positive titers should also be tested for other tick-borne diseases.
Tube / Specimen Requirements
1 SST/ minimum volume 0.5mL serum
CPT Code(s)
86753 x2
Sample Report
View
IFA
Available in New YorkYes
• Indirect testing, and therefore useful when the pathogens are hiding, but eliciting an immune response.
• Active infection may be indicated when either IgM only, IgM and IgG, or IgG (≥ 160) antibodies are present.
IgM
< 20 Negative
20 May or may not indicate active infection.
≥ 40 Indicates active infection.
IgG
< 40 Negative
≥ 40 to < 160 May or may not suggest active infection. In patients with previously high titers, such titers may indicate resolving infection.
≥ 160 Indicates active infection.
The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.
1.800.832.3200
For the most up to date and accurate information and articles about ticks and tick-borne diseases, please visit Tick Talk Resource.
Enter your email address to receive periodic marketing communications from IGeneX.